FDA
FDA contract intelligence
Food and Drug Administration work in the public record covers Regulatory science, safety surveillance, submissions, inspections, product centers, data modernization, AI/ML validation.
- Programs named in that record include adverse events, compliance, Sentinel, and real-world evidence.
- Named officials on the public roster include Kyle Diamantas, Acting Commissioner of Food and Drugs, Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs, Michael Davis, Director, Center for Drug Evaluation and Research, and Karim Mikhail, Director, Center for Biologics Evaluation and Research.
- Official pages include fda.gov, fda.gov (strategic plan regulatory science), fda.gov (budgets), and SAM.gov.
This week's public sample
Leader statement
Karim Mikhail, Director, Center for Biologics Evaluation and Research said on October 30, 2026: "Adults living with recurrent respiratory papillomatosis often face an exhausting and relentless cycle of repeated surgeries, managing their disease, but never truly escaping it." FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Res
Recompete
Verily Health Inc. holds the current award, which ends September 28, 2027. USAspending record
This week's sample is a public recompete or notice, and a leader line when the agency site has one. Dates are the end date or the response date in that public record. GovCon Health OS is not a government agency and is not affiliated with one.